logo

Sirona Biochem Corp. (SBM.V)



Trade SBM.V now with
  Date
  Headline
12/19/2019 3:06:20 AM Sirona Biochem Provides Update To Shareholders; Says Remain Committed To Increasing Shareholder Value Through 2020
10/9/2019 3:04:51 AM Sirona Biochem Completes Binding Term Sheet With Tinyi Trading Company
9/18/2019 3:08:34 AM Sirona Biochem Completes Definitive Agreement With Rodan + Fields, LLC
7/3/2019 3:14:38 AM Sirona Biochem Says Clinical Development Of SGLT2 Inhibitor TFC-039 Is Progressing On Schedule With No Adverse Events
6/17/2019 3:04:44 AM Sirona Biochem Says TFC-1067 Skin Lightening Patent Granted In US
6/11/2019 3:12:13 AM Sirona Biochem Secure Approval To Test Higher Concentrations Of Skin Lightening Compound TFC-1067
4/10/2019 3:03:18 AM Sirona Biochem's TFC-1067 Shows Superiority To Hydroquinone For Treatment Of Dyschromia
7/12/2018 8:06:27 AM Sirona Biochem Announces CFDA Approval Of SGLT2 Inhibitor For Phase I Clinical Trial
  
 
>